These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4003420)

  • 41. Overfill of common piggyback admixture solutions.
    Kleinberg ML; Chang P
    Hosp Pharm; 1984 Oct; 19(10):657-8, 662-3, 666-70 passim. PubMed ID: 10268316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient-controlled analgesia versus intramuscular analgesic therapy.
    Smythe M; Loughlin K; Schad RF; Lucarroti RL
    Am J Hosp Pharm; 1994 Jun; 51(11):1433-40. PubMed ID: 7942878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of methods and costs of preparing intravenous piggyback solutions.
    Grey C
    Hosp Pharm; 1976 Jun; 11(6):214, 18, 21-2. PubMed ID: 1026705
    [No Abstract]   [Full Text] [Related]  

  • 44. Time and cost analysis of a computerized outpatient pharmacy.
    Unertl GC; Wiederholt JB; Peterson CR
    Am J Hosp Pharm; 1984 Jun; 41(6):1131-6. PubMed ID: 6741955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined volume control set-piggyback system for intermittent intravenous therapy.
    Paxinos J; Samuels TM
    Am J Hosp Pharm; 1975 Sep; 32(9):892-7. PubMed ID: 1190244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activity analysis of sterile products technicians.
    Scala SM; Anderson E
    Hosp Pharm; 1992 Dec; 27(12):1089-90, 1092, 1094-5. PubMed ID: 10122512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost of computerized drug interaction screening system.
    Greenlaw CW
    Am J Hosp Pharm; 1981 Apr; 38(4):521-4. PubMed ID: 7282679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hospital-based training for pharmaceutical manufacturers' representatives.
    Powell SH; Stempien MJ; Vogenberg FR
    Am J Hosp Pharm; 1984 Jan; 41(1):70, 74. PubMed ID: 6695935
    [No Abstract]   [Full Text] [Related]  

  • 49. Reducing costs with formulary limitation of H2-receptor antagonists in a community hospital.
    Coppola P
    Hosp Pharm; 1991 Feb; 26(2):126-9, 142. PubMed ID: 10136547
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identifying economic efficiencies resulting from a drug prepackaging program.
    Campbell WH; Christensen DB; Johnson RE; Booker SF
    Am J Hosp Pharm; 1974 Oct; 31(10):954-60. PubMed ID: 4440693
    [No Abstract]   [Full Text] [Related]  

  • 52. Evaluation of gentamicin premixed admixtures: cost and clinical utility.
    Zarowitz BJ; Owen H; Popovich J; Pancorbo S
    Hosp Pharm; 1987 Mar; 22(3):257-60. PubMed ID: 10311980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of drug costs within diagnosis related groups.
    Kolar R; Stanaszek W; Osborne J; Dougherty K
    Hosp Pharm; 1984 Nov; 19(11):731-5. PubMed ID: 10310864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-benefit analysis of a hospital pharmacy bar code solution.
    Maviglia SM; Yoo JY; Franz C; Featherstone E; Churchill W; Bates DW; Gandhi TK; Poon EG
    Arch Intern Med; 2007 Apr; 167(8):788-94. PubMed ID: 17452541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Examining the production costs of antiretroviral drugs.
    Pinheiro E; Vasan A; Kim JY; Lee E; Guimier JM; Perriens J
    AIDS; 2006 Aug; 20(13):1745-52. PubMed ID: 16931939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of a new semi-rigid intravenous container.
    Levine HG; Hanan ZI
    Hosp Pharm; 1980 Mar; 15(3):124-6, 128-9, 132-3 passim. PubMed ID: 10245912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Financial impact of formulary revision of second-generation cephalosporins.
    Andrews JD; Hafting S
    Can J Hosp Pharm; 1988 Jun; 41(3):125-7. PubMed ID: 10288499
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Premixed intravenous admixtures: a positive development for hospital pharmacy.
    Lee HE
    Am J Hosp Pharm; 1983 Jun; 40(6):1043-4. PubMed ID: 6869393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of the accuracy of unit dose cart fill with the Baxter ATC-212 computerized system and manual filling.
    Kratz K; Thygesen C
    Hosp Pharm; 1992 Jan; 27(1):19-20, 22. PubMed ID: 10116118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Price differences between single-dose and bulk-packaged vials of ampicillin.
    Fontana LC
    Am J Hosp Pharm; 1978 Sep; 35(9):1032, 1034. PubMed ID: 696741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.